Dr Reddy's Laboratories on Thursday reported a 2% year-on-year growth in its December quarter consolidated net profit at Rs 1,413 crore versus Rs 1,379 crore posted in the year ago period. The Q3FY25 revenue from operations stood at Rs 8,359 crore which was up by 16% over Rs 7215 in the corresponding quarter of the previous financial year.
The profit after tax (PAT) is attributable to the equity holders of the company.
<div data-placement=«Mid Article Thumbnails» data-target_type=«mix» data-mode=«thumbnails-mid» style=«min-height:400px; margin-bottom:12px;» class=«wdt-taboola» id=«taboola-mid-article-thumbnails-117487968»>
Company's Earnings Before Interest, Taxes, Depreciation and Amortisation (EBITDA) for the reported quarter stood at Rs 2,298 crore which is 27.5% of company's revenues.
<div data-placement=«Mid Article Thumbnails» data-target_type=«mix» data-mode=«thumbnails-mid» style=«min-height:400px; margin-bottom:12px;» class=«wdt-taboola» id=«taboola-mid-article-thumbnails-117487968»> <div data-placement=«Mid Article Thumbnails» data-target_type=«mix» data-mode=«thumbnails-mid» style=«min-height:400px; margin-bottom:12px;» class=«wdt-taboola» id=«taboola-mid-article-thumbnails-117487968»>
More to come...
(You can now subscribe to our ETMarkets WhatsApp channel)
Read more on economictimes.indiatimes.com